ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?
Global drug pricing: How cost-effective is bevacizumab?
Trial shows exercise beneficial for patients undergoing chemotherapy
Hypo-fractionation of prostate cancer radiotherapy
Hodgkins - update on treatment strategies in children and adolescents
Use of novel agents in childhood ALL
Oncology for children: what can be done when resources are scarce?
First outcome results from MINDACT breast cancer clinical trial
Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer
Physical activity may improve prostate cancer prognosis
Innovations in assessing patient outcomes
Editor's Choice for April 2016